Incretin analogues that have been developed to treat type 2 diabetes hold promise as a novel treatment strategy for Alzheimer's disease

Christian Holscher

    Research output: Contribution to journalArticlepeer-review

    89 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)109-117
    JournalRecent Patents on CNS Drug Discovery
    Volume5
    Publication statusPublished (in print/issue) - 2010

    Cite this